Tennessee House Bill HB1333

Tennessee 2023-2024 Regular Session

• Introduced: 1/31/23
• Refer: 2/2/23

Caption

AN ACT to amend Tennessee Code Annotated, Title 4; Title 7; Title 56; Title 63; Title 68 and Title 71, relative to breast cancer.

Note

By focusing on a specific demographic, HB1333 suggests a broader dialogue about health equity and access to care that could resonate throughout other areas of public health legislation in Tennessee. The bill reflects an understanding of the systemic issues within healthcare and aims to create a framework for addressing these disparities head-on.

Impact

With the establishment of the Commission on African American Breast Cancer Research, the bill is expected to have significant implications for state health policies. The commission will be responsible for investigating critical areas such as the risk factors, frequency of diagnoses, and availability of screenings and educational resources related to breast cancer in African American communities. By identifying these issues, the commission aims to make informed recommendations to improve healthcare access and outcomes for the population it serves. The bill also mandates that annual reports be submitted to state leadership, ensuring ongoing oversight and accountability.

Summary

House Bill 1333 aims to address the issues surrounding breast cancer in African American women in Tennessee by establishing a dedicated commission focused on research and education in this area. The bill proposes to amend several titles in the Tennessee Code Annotated to create a structured body that will investigate the incidence, diagnosis, and preventive measures concerning breast cancer among African American women. This initiative stems from the recognition of disparities in healthcare outcomes and access that disproportionately affect this demographic, emphasizing the need for targeted efforts to enhance awareness and treatment options.

Contention

While the intent of HB1333 is largely seen as benevolent, there may be points of contention related to funding and resource allocation. Critics could raise concerns about the practical implications of implementing the commission’s recommendations, particularly if it requires significant financial investment or changes to existing health policies. Additionally, the effectiveness of the commission will hinge on its ability to operate without bureaucratic constraints that may limit its reach or efficacy in addressing the specific needs of African American women regarding breast cancer.